- Home
- ADNT vs BLFS Comparison
ADNT vs BLFS Comparison
Compare ADNT & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADNT
- BLFS
- Stock Information
- Founded
- ADNT 2016
- BLFS 1987
- Country
- ADNT Ireland
- BLFS United States
- Employees
- ADNT N/A
- BLFS N/A
- Industry
- ADNT Auto Parts:O.E.M.
- BLFS Medical/Dental Instruments
- Sector
- ADNT Consumer Discretionary
- BLFS Health Care
- Exchange
- ADNT Nasdaq
- BLFS Nasdaq
- Market Cap
- ADNT 1.4B
- BLFS 1.2B
- IPO Year
- ADNT N/A
- BLFS 1989
- Fundamental
- Price
- ADNT $12.68
- BLFS $22.83
- Analyst Decision
- ADNT Hold
- BLFS Strong Buy
- Analyst Count
- ADNT 9
- BLFS 8
- Target Price
- ADNT $20.88
- BLFS $29.50
- AVG Volume (30 Days)
- ADNT 2.2M
- BLFS 434.8K
- Earning Date
- ADNT 05-02-2025
- BLFS 03-03-2025
- Dividend Yield
- ADNT N/A
- BLFS N/A
- EPS Growth
- ADNT N/A
- BLFS N/A
- EPS
- ADNT N/A
- BLFS N/A
- Revenue
- ADNT $14,523,000,000.00
- BLFS $82,254,000.00
- Revenue This Year
- ADNT N/A
- BLFS $20.68
- Revenue Next Year
- ADNT $1.57
- BLFS $21.74
- P/E Ratio
- ADNT N/A
- BLFS N/A
- Revenue Growth
- ADNT N/A
- BLFS 8.44
- 52 Week Low
- ADNT $12.31
- BLFS $14.84
- 52 Week High
- ADNT $32.49
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- ADNT 33.03
- BLFS 36.44
- Support Level
- ADNT $12.31
- BLFS $25.03
- Resistance Level
- ADNT $15.14
- BLFS $26.30
- Average True Range (ATR)
- ADNT 0.74
- BLFS 1.42
- MACD
- ADNT -0.06
- BLFS -0.21
- Stochastic Oscillator
- ADNT 12.90
- BLFS 20.39
About ADNT Adient plc
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.8 billion in fiscal 2024 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2024 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.7 billion.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.